About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiology
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
R
Important Safety Information - Off-Target Effects of New Therapies for Diabetes: SGLT2 Inhibitors
By
Ronald Goldenberg
2 Videos
0 views
July 1, 2024
Comments
0
Login to view comments.
Click here to Login
Featured Video
18:06
Lilly Obesity
Getting Patients Started with an Obesity Treatment Option for Adults
Feat.
E. Lazarus
Featured Video
48:22
Lilly Diabetes
A Journey Through Clinical Efficacy and Safety Data Comparing Two T2…
Feat.
B. Hirsch
Recommended
AUTOPLAY
ON
64:45
Symposium on Diabetes and Cancer 2017: Novel Links and Treatments
Primer on Diabetes Management
Feat.
S. Inzucchi
19:15
Omnipod®
Omnipod 5® Learning Bytes Presentation: Unusual Suspects for AID
Feat.
D. Desalvo
05:38
The North American Thrombosis Forum (NATF)
Vitamin D: How Does It Work? What's the “Right” Level?
Feat.
C. J. Rosen
31:30
UCSF School of Medicine
Vitamin D and its Supplementation: Where is the Evidence and Should …
Feat.
C. J. Rosen
11:37
ACC 2022 Conference Coverage
ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…
Feat.
P. Heidenreich
11:25
ACC 2023 Conference Coverage
ACC 2023: SGLT2i Use - Dos and Don'ts
Feat.
A. Armbruster
24:56
Sonali Khandelwal
Osteoporosis Medications: When to Continue and When to Stop?
61:49
Obafemi Awolowo University
Management of Heart Failure
Feat.
O. A. Akinyele
18:43
ASPC 2019 Congress on CVD Prevention
Diabetes Treatment Guidelines Finally Have Entered the 21st Century …
Feat.
R. DeFronzo
07:01
John Tayek
Osteoporosis & Vitamin D: Does Vitamin D Reduce Falls/Fractures …
37:21
University of Colorado Department of Medicine
Evidence that Obesity and Diabetes are Driven by a Diet-Induced Biol…
Feat.
R. Johnson
08:46
Robert Busch
FLOW Trial Results: GLPs, the Kidneys, and Even More to Come!!
26:01
Cardiology Fiesta 2017
Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibiti…
Feat.
R. DeFronzo
18:44
ACR Convergence 2021 Coverage
Calcium and Vitamin D Supplementation to Prevent and Manage Osteopor…
Feat.
N. Lane
17:44
Rita Jermyn
SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease
27:24
Cardiometabolic Health Congress (CMHC)
SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes
Feat.
L. Sloan
26:49
Diana Isaacs
Tirzepatide Updates
34:19
Michigan Medicine - Podiatry
Perioperative Management of Anticoagulants: Podiatry Education Series
Feat.
M. Munson
33:23
Keck School of Medicine of USC
Effects of Low Calorie and Alternative Sweeteners Across the Lifespa…
Feat.
M. Goran
19:33
ARCH Advanced Revascularization Symposium
Contrast Nephropathy
